Rosenheck, R., Stroup, S., Keefe, R.S.E., et al. (2005). Measuring outcome priorities and preferences in people with schizophrenia. British Journal of Psychiatry, 187, 529–34.CrossRefGoogle ScholarPubMed

Wiersma, D. (2006). Needs of people with severe mental illness. Acta Psychiatrica Scandinavica Supplementa, 429, 115–19.Google Scholar

Torres-Gonzalez, F., Ibanez-Casas, I., Saldivia, S., et al. (2014). Unmet needs in the management of schizophrenia. Neuropsychiatric Disease and Treatment, 10, 97–110.CrossRefGoogle ScholarPubMed

Hansson, L., Sandlund, M., Bengtsson-Tops, A., et al. (2003). The relationship of needs and quality of life in persons with schizophrenia living in the community: a Nordic multi-center study. Nordic Journal of Psychiatry, 57, 5–11.CrossRefGoogle ScholarPubMed

Slade, M., Leese, M., Taylor, R., Thornicroft, G. (1999). The association between needs and quality of life in an epidemiologically representative sample of people with psychosis. Acta Psychiatrica Scandanivica, 100(2), 149–57.Google Scholar

Slade, M., Leese, M., Cahill, S., Thornicroft, G., Kuipers, E. (2005). Patient-rated mental health needs and quality of life improvement. British Journal of Psychiatry, 187, 256–61.CrossRefGoogle ScholarPubMed

Priebe, S., Huxley, P., Burns, T. (1999). Who needs needs? European Psychiatry, 14, 186–8.CrossRefGoogle ScholarPubMed

Wing, J.K. (1990). Meeting the needs of people with psychiatric disorders. Social Psychiatry and Psychiatric Epidemiology, 25(1), 2–8.CrossRefGoogle ScholarPubMed

Reynolds, T., Thornicroft, G., Abas, M., et al. (2000). Camberwell Assessment of Need for the Elderly (CANE): development, validity and reliability. British Journal of Psychiatry, 176, 444–52.CrossRefGoogle ScholarPubMed

Phelan, M., Slade, M., Thornicroft, G., et al. (1995). The Camberwell Assessment of Need: the validity and reliability of an instrument to assess the needs of people with severe mental illness. British Journal of Psychiatry, 167(5), 589–95.CrossRefGoogle ScholarPubMed

McNulty, S.V., Duncan, L., Semple, M., Jackson, G.A., Pelosi, A.J. (2003). Care needs of elderly people with schizophrenia: assessment of an epidemiologically defined cohort in Scotland. British Journal of Psychiatry, 182, 241–7.CrossRefGoogle ScholarPubMed

Auslander, L.A., Jeste, D.V. (2002). Perceptions of problems and needs for service among middle-aged and elderly outpatients with schizophrenia and related psychotic disorders. Community Mental Health Journal, 38(5), 391–402.CrossRefGoogle ScholarPubMed

Futeran, S., Draper, B.M. (2012). An examination of the needs of older patients with chronic mental illness in public mental health services. Aging and Mental Health, 16(3), 327–34.CrossRefGoogle ScholarPubMed

Meesters, P.D., Comijs, H.C., Dröes, R.-M., et al. (2013). The care needs of elderly patients with schizophrenia spectrum disorders. American Journal of Geriatric Psychiatry, 21(2), 129–37.CrossRefGoogle ScholarPubMed

Wiersma, D., van den Brink, R., Wolters, K., et al. (2009). Individual unmet needs for care: are they sensitive as outcome criterion for the effectiveness of mental health services interventions? Social Psychiatry and Psychiatric Epidemiology, 44, 317–24.CrossRefGoogle ScholarPubMed

Houtjes, W., van Meijel, B., Deeg, D.J.H., Beekman, A.T.F. (2010). Major depressive disorder in late life: a multifocus perspective on care needs. Aging and Mental Health, 14(7), 874–80.CrossRefGoogle ScholarPubMed

van der Roest, H.G., Meiland, F.J., Comijs, H.C., et al. (2009). What do community-dwelling people with dementia need? A survey of those who are known to care and welfare services. International Psychogeriatrics, 21(5), 949–65.CrossRefGoogle Scholar

Walters, K., Iliffe, S., Tai, S.S., Orrell, M. (2000). Assessing needs from patient, carer and professional perspectives: the Camberwell assessment of need for elderly people in primary care. Age and Ageing, 29, 505–10.CrossRefGoogle ScholarPubMed

Field, E., Walker, M., Orrell, M. (2004). The needs of older people living in sheltered housing. In CANE: Camberwell Assessment of Need for the Elderly; A Needs Assessment for Older Mental Health Service Users, ed. Orrell, M., Hancock, G. London, UK: Gaskell, 35–44.Google Scholar

McCrone, P., Leese, M., Thornicroft, G., et al. (2001). A comparison of needs of patients with schizophrenia in five European countries: the EPSILON Study. Acta Psychiatrica Scandinavica, 103, 370–9.CrossRefGoogle ScholarPubMed

De Hert, M., Cohen, D., Bobes, J., et al. (2011). Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry, 10(2), 138–51.CrossRefGoogle ScholarPubMed

Vahia, I.V., Diwan, S., Bankole, A.O., et al. (2008). Adequacy of medical treatment among older persons with schizophrenia. Psychiatric Services, 59(8), 853–9.CrossRefGoogle ScholarPubMed

Lahti, M., Tiihonen, J., Wildgust, H., et al. (2012). Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychological Medicine, 42(11), 2275–85.CrossRefGoogle ScholarPubMed

Meesters, P.D., Comijs, H.C., de Haan, L., et al. (2011). Symptomatic remission and associated factors in a catchment area based population of older patients with schizophrenia. Schizophrenia Research, 126(1–3), 237–44.CrossRefGoogle Scholar

Cohen, C. I., Iqbal, M. (2014). Longitudinal study of remission among older adults with schizophrenia spectrum disorder. American Journal of Geriatric Psychiatry, 22(5), 450–8.CrossRefGoogle ScholarPubMed

Cohen, C.I., Hassamal, S.K., Begum, N. (2011). General coping strategies and their impact on quality of life in older adults with schizophrenia. Schizophrenia Research, 127(1–3), 223–8.CrossRefGoogle ScholarPubMed

Liberman, R.P., Wallace, C.J., Blackwell, G., et al. (1998). Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. American Journal of Psychiatry, 155, 1087–91.CrossRefGoogle ScholarPubMed

Achim, A.M., Maziade, M., Raymond, É., et al. (2011). How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophrenia Bulletin, 37(4), 811–21.CrossRefGoogle ScholarPubMed

van den Berg, D. (2015). Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry, 72, 259–67.CrossRefGoogle ScholarPubMed

Meesters, P.D., Stek, M.L., Comijs, H.C., et al. (2010). Social functioning among older community-dwelling patients with schizophrenia: a review. American Journal of Geriatric Psychiatry, 18(10), 862–78.CrossRefGoogle ScholarPubMed

Beard, J., Propst, R., Mulamud, T. (1982). The Fountain House model of psychiatric rehabilitation. Psychosocial Rehabilitation Journal, 5(1), 47–53.Google Scholar

Warner, R., Huxley, P., Berg, T. (1999). An evaluation of the impact of clubhouse membership on quality of life and treatment utilization. International Journal of Social Psychiatry, 45(4), 310–20.CrossRefGoogle ScholarPubMed

Meesters, P.D., van der Ham, L., Dominicus, M., Stek, M.L., Abma, T. (2018). Promoting personal and social recovery in older persons with schizophrenia: the case of the New Club, a novel Dutch facility offering social contact and activities. Submitted.Google Scholar

Depla, M.F.I., de Graaf, R., van Weeghel, J., Heeren, T.J. (2005). The role of stigma in the quality of life of older adults with severe mental illness. International Journal of Geriatric Psychiatry, 20, 146–53.CrossRefGoogle ScholarPubMed

Berry, K., Purandare, N., Drake, R., et al. (2013). A mixed-methods evaluation of a pilot psychosocial intervention group for older people with schizophrenia. Behavioural and Cognitive Psychotherapy, 42(2), 199–210.CrossRefGoogle Scholar

Granholm, E., Holden, J., Link, P.C., McQuaid, J.R., Jeste, D.V. (2013). Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. American Journal of Geriatric Psychiatry, 21(3), 251–62.CrossRefGoogle ScholarPubMed

Patterson, T.L., Mausbach, B.T., McKibbin, C., et al. (2006). Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophrenia Research, 86(1–3), 291–9.CrossRefGoogle Scholar

Mueser, K.T., Bartels, S.J., Santos, M., Pratt, S.I., Riera, E.G. (2012). Integrated illness management and recovery: a program for integrating physical and psychiatric illness self-management in older persons with severe mental illness. American Journal of Psychiatric Rehabilitation, 15, 131–56.CrossRefGoogle Scholar

Kreyenbuhl, J., Nossel, I.R., Dixon, L.B. (2009). Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature. Schizophrenia Bulletin, 35(4), 696–703.CrossRefGoogle Scholar

Mojtabai, R., Fochtmann, L., Chang, S.-W., et al. (2009). Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study. Schizophrenia Bulletin, 35(4), 679–95.CrossRefGoogle ScholarPubMed

Stobbe, J., Wierdsma, A.I., Kok, R.M., et al. (2013). Lack of motivation for treatment associated with greater care needs and psychosocial problems. Aging and Mental Health, 17(8), 1052–8.CrossRefGoogle ScholarPubMed

Stobbe, J., Wierdsma, A.I., Kok, R.M., et al. (2014). Decrease in unmet needs contributes to improved motivation for treatment in elderly patients with severe mental illness. Social Psychiatry and Psychiatric Epidemiology, 50(1), 125–32.Google ScholarPubMed

Cho, S, Lau, SW, Tandon, V, et al. Geriatric drug evaluation. Archives of Internal Medicine. 2011; 171(10): 937–40.CrossRefGoogle ScholarPubMed

Wecker, L, Crespo, L, Dunway, G. Treatment of psychotic disorders. In Brody's Human Pharmacology, ed. Wecker, L, Taylor, DA, Theobald, RJ Jr. Philadelphia, PA: Elsevier, 2012: 324–31.Google Scholar

Uchida, H, Suzuki, T, Graff-Guerrero, A, et al. Therapeutic window for striatal dopamine D2/3 receptor occupancy in older patients with schizophrenia. American Journal of Geriatric Psychiatry. 2014; 22(10): 1007–16.CrossRefGoogle Scholar

Graff-Guerrero, A, Rajji, TK, Mulsant, BH, et al. Evaluation of antipsychotic dose reduction in late-life schizophrenia. JAMA Psychiatry. 2015; 72(9): 927.CrossRefGoogle ScholarPubMed

Nakajima, S, Caravaggio, F, Mamo, DC, et al. Dopamine D2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia: a [11C]-raclopride PET study. Schizophrenia Research. 2015; 164(1–3): 263–7.CrossRefGoogle ScholarPubMed

Questions and answers about the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE): Phase 1 results. www.nimh.nih.gov/funding/clinical-research/practical/catie/phase1results.shtml (accessed October 2018).Google Scholar

Swartz, MS, Stroup, TS, Mcevoy, JP, et al. Special section on implications of CATIE: What CATIE found: results from the schizophrenia trial. Psychiatric Services. 2008; 59(5): 500–6.CrossRefGoogle Scholar

Leucht, S, Cipriani, A, Spineli, L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis Lancet. 2013; 382(9896): 951–62.CrossRefGoogle ScholarPubMed

Sakauye, K. Geriatric Psychiatry Basics. New York: WW Norton, 2008.Google Scholar

Howanitz, E, Pardo, M, Smelson, DA, et al. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. Journal of Clinical Psychiatry. 1999; 60(1): 41–4.Google ScholarPubMed

Altamura, AC, Mauri, MC, Girardi, T, Panetta, B. Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia. International Journal of Clinical Pharmacology Research. 1990; 10(4): 223–8.Google ScholarPubMed

Weisbard, JJ, Pardo, M, Pollack, S. Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics. Psychopharmacology Bulletin. 1997; 33(1): 119–22.Google ScholarPubMed

Mohler, G. Clinical trial of thiothixene (Navane) in elderly chronic schizophrenics. Current Therapeutic Research. 1970; 12(6): 377–86.Google ScholarPubMed

Branchey, MH, Lee, JH, Simpson, GM, Elgart, B, Vicencio, A. Loxapine succinate as a neuroleptic agent: evaluation in two populations of elderly psychiatric patients. Journal of the American Geriatric Society. 1978; 26(6): 263–7.CrossRefGoogle ScholarPubMed

Oberholzer, AF, Hendriksen, C, Monsch, AU, Heierli, B, Sthelin, HB. Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study. International Psychogeriatrics. 1992; 4(2): 187–95.CrossRefGoogle ScholarPubMed

O'Connor, D, Sierakowski, C, Chin, L, Singh, D. The safety and tolerability of clozapine in aged patients: a retrospective clinical file review. World Journal of Biological Psychiatry. 2010; 11(6): 788–91.CrossRefGoogle ScholarPubMed

Pitner, JK, Mintzer, JE, Pennypacker, LC, Jackson, CW. Efficacy and adverse effects of clozapine in four elderly psychotic patients. Journal of Clinical Psychiatry. 1995; 56(5): 180–5.Google ScholarPubMed

Pridan, S, Swartz, M, Baruch, Y, et al. Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia. International Psychogeriatrics. 2015; 27(1): 131–4.CrossRefGoogle ScholarPubMed

Sajatovic, M, Ramirez, LF, Garver, D, et al. Clozapine therapy for older veterans. Psychiatric Services. 1998; 49(3): 340–4.CrossRefGoogle ScholarPubMed

Chengappa, KN, Baker, RW, Kreinbrook, SB, Adair, D. Clozapine use in female geriatric patients with psychoses. Journal of Geriatric Psychiatry and Neurology. 1995; 8(1): 12–15.Google ScholarPubMed

Frankenburg, F, Kalunian, D. Clozapine in the elderly. Journal of Geriatric Psychiatry and Neurology. 1994; 7(2): 129–32.CrossRefGoogle ScholarPubMed

Salzman, C, Vaccaro, B, Lieff, J, Weiner, A. Clozapine in older patients with psychosis and behavioral disruption. American Journal of Geriatric Psychiatry. 1995; 3(1): 26–33.CrossRefGoogle ScholarPubMed

Sajatovic, M, Jaskiw, G, Konicki, PE, et al. Outcome of clozapine therapy for elderly patients with refractory primary psychosis. International Journal of Geriatric Psychiatry. 1997; 12(5): 553–8.3.0.CO;2-U>CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brecher, M, Brenner, R, et al. Risperidone in the treatment of elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry. 1999; 7(2): 132–8.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Suresh, P, Brenner, R, Pillai, R. Experience with the atypical antipsychotics risperidone and olanzapine in the elderly. Annals of Clinical Psychiatry. 1999; 11(3): 113–18.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brenner, R, Araujo, L, Abaza, A. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. Journal of Clinical Psychiatry. 1995; 56(11): 514–18.Google ScholarPubMed

Davidson, M, Harvey, PD, Vervarcke, J, et al. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. International Journal of Geriatric Psychiatry. 2000; 15(6): 506–14.3.0.CO;2-V>CrossRefGoogle ScholarPubMed

Sajatovic, M, Ramirez, LF, Vernon, L, et al. Outcome of risperidone therapy in elderly patients with chronic psychosis. International Journal of Psychiatry in Medicine. 1996; 26(3): 309–17.CrossRefGoogle ScholarPubMed

Berman, I, Merson, A, Rachov-Pavlov, J, et al. Risperidone in elderly schizophrenic patients: an open-label trial. American Journal of Geriatric Psychiatry. 1996; 4(2): 173–9.CrossRefGoogle ScholarPubMed

Berman, I, Merson, A, Sison, C, et al. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study. Psychopharmacology Bulletin. 1996; 32(1): 95–100.Google ScholarPubMed

Bullock, R, Libretto, S. Risperidone in the treatment of psychoses in the elderly: a case report series. European Psychiatry. 2002; 17(2): 96–103.CrossRefGoogle ScholarPubMed

Kiraly, SJ, Gibson, RE, Ancill, RJ, Holliday, SG. Risperidone: treatment response in adult and geriatric patients. International Journal of Psychiatry in Medicine. 1998; 28(2): 255–63.CrossRefGoogle ScholarPubMed

Barak, Y, Shamir, E, Weizman, R. Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study. Journal of Clinical Psychopharmacology. 2002; 22(2): 115–20.CrossRefGoogle ScholarPubMed

Jeste, DV, Eastham, JH, Lacro, JP, et al. Management of late-life psychosis. Journal of Clinical Psychiatry. 1996; 57(Suppl 3): 39–45; discussion 49–50.Google ScholarPubMed

Zarate, CA Jr, Baldessarini, RJ, Siegel, AJ, et al. Risperidone in the elderly: a pharmacoepidemiologic study. Journal of Clinical Psychiatry. 1997; 58(7): 311–17.Google ScholarPubMed

Tadger, S, Baruch, Y, Barak, Y. Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone. International Psychogeriatrics. 2008; 20(6): 1245–50.CrossRefGoogle ScholarPubMed

Lasser, RA, Bossie, CA, Zhu, Y, et al. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder. International Journal of Geriatric Psychiatry. 2004; 19(9): 898–905.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brecher, M, Brenner, R, et al. Risperidone in the treatment of elderly patients with psychotic disorders. American Journal of Geriatric Psychiatry. 1999; 7(2): 132–8.CrossRefGoogle ScholarPubMed

Verma, S, Orengo, C, Kunik, M, Hale, D, Molinari, V. Tolerability and effectiveness of atypical antipsychotics in male geriatric inpatients. International Journal of Geriatric Psychiatry. 2001; 16(2): 223–7.3.0.CO;2-R>CrossRefGoogle ScholarPubMed

Jeste, DV, Barak, Y, Madhusoodanan, S, Grossman, F, Gharabawi, G. International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. American Journal of Geriatric Psychiatry. 2003; 11(6): 638–47.CrossRefGoogle ScholarPubMed

Frenchman, I. Risperidone, haloperidol, and olanzapine for the treatment of behavioral disturbances in nursing home patients: a retrospective analysis. Current Therapeutic Research. 2000; 61(10): 742–50.Google Scholar

Madhusoodanan, S, Suresh, P, Brenner, R, Pillai, R. Experience with the atypical antipsychotics risperidone and olanzapine in the elderly. Annals of Clinical Psychiatry. 1999; 11(3): 113–18.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brenner, R, Suresh, P, et al. Efficacy and tolerability of olanzapine in elderly patients with psychotic disorders: a prospective study. Annals of Clinical Psychiatry. 2000; 12(1): 11–18.CrossRefGoogle ScholarPubMed

Barak, Y, Shamir, E, Mirecki, I, Weizman, R, Aizenberg, D. Switching elderly chronic psychotic patients to olanzapine. International Journal of Neuropsychopharmacology. 2004; 7(2): 165–9.CrossRefGoogle ScholarPubMed

Sajatovic, M, Perez, D, Brescan, D, Ramirez, LF. Olanzapine therapy in elderly patients with schizophrenia. Psychopharmacology Bulletin. 1998; 34(4): 819–23.Google ScholarPubMed

Street, S, Tollefson, G, Tohen, M, et al. Olanzapine for psychotic conditions in the elderly. Psychiatric Annals. 2000; 30(3): 191–6.CrossRefGoogle Scholar

Solomons, K, Geiger, O. Olanzapine use in the elderly: a retrospective analysis. Canadian Journal of Psychiatry. 2000; 45(2): 151–5.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brenner, R, Alcantra, A. Clinical experience with quetiapine in elderly patients with psychotic disorders. Journal of Geriatric Psychiatry and Neurology. 2000; 13(1): 28–32.CrossRefGoogle ScholarPubMed

McManus, DQ, Arvanitis, LA, Kowalcyk, BB. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Journal of Clinical Psychiatry. 1999; 60(5): 292–8.Google ScholarPubMed

Tariot, PN, Salzman, C, Yeung, PP, Pultz, J, Rak, IW. Long-term use of quetiapine in elderly patients with psychotic disorders. Clinical Therapeutics. 2000; 22(9): 1068–84.CrossRefGoogle ScholarPubMed

Yang, CH, Tsai, SJ, Hwang, JP. The efficacy and safety of quetiapine for treatment of geriatric psychosis. Journal of Psychopharmacology. 2005; 19(6): 661–6.CrossRefGoogle ScholarPubMed

Barak, Y, Mazeh, D, Plopski, I, Baruch, Y. Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. American Journal of Geriatric Psychiatry. 2006; 14(7): 629–33.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brenner, R, Gupta, S, Reddy, H, Bogunovic, O. Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder: retrospective case studies. CNS Spectrums. 2004; 9(11): 862–7.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Brenner, R, Serper, MR, Adelsky, M, Adler, DN. Use of paliperidone in elderly patients with schizophrenia and schizoaffective disorder: a prospective open-label short-term pilot study. Journal of Clinical Psychopharmacology. 2011; 31(3): 380–2.CrossRefGoogle ScholarPubMed

Tzimos, A, Samokhvalov, V, Kramer, M, et al. Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia: a double-blind, placebo-controlled study with six-month open-label extension. American Journal of Geriatric Psychiatry. 2008; 16(1): 31–43.CrossRefGoogle ScholarPubMed

Barak, Y, Finkelstein, I, Pridan, S. The geriatric mania asenapine study (GeMS). Archives of Gerontology and Geriatrics. 2016; 64: 111–14.CrossRefGoogle ScholarPubMed

Sajatovic, M, Dines, P, Fuentes-Casiano, E, et al. Asenapine in the treatment of older adults with bipolar disorder. International Journal of Geriatric Psychiatry. 2015; 30(7): 710–19.CrossRefGoogle ScholarPubMed

Sajatovic, M, Forester, BP, Tsai, J, et al. Efficacy of lurasidone in adults aged 55 years and older with bipolar depression: post hoc analysis of 2 double-blind, placebo-controlled studies. Journal of Clinical Psychiatry. 2016; 77(10): e1324–e1331.CrossRefGoogle ScholarPubMed

Hoffman, WF, Ballard, L, Turner, EH, et al. Three-year follow up of older schizophrenics: extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio. Biological Psychiatry. 1991; 30(9): 913–26.CrossRefGoogle ScholarPubMed

Brenner, GM, Stevens, C. Psychotherapeutic drugs. In Pharmacology. Philadelphia, PA: Saunders, 2013: 221–37.Google Scholar

Balaraman, R, Gandhi, H. Asenapine, a new sublingual atypical antipsychotic. Journal of Pharmacology and Pharmacotherapeutics. 2010; 1(1): 60.Google ScholarPubMed

Highlights of prescribing information: Latuda. www.accessdata.fda.gov/drugsatfda_docs/label/2017/200603s26s27lbl.pdf (accessed October 2018).Google Scholar

Highlights of prescribing information: Geodon. www.labeling.pfizer.com/ShowLabeling.aspx?id=584 (accessed October 2018).Google Scholar

Highlights of prescribing information: Seroquel XR. www.accessdata.fda.gov/drugsatfda_docs/label/2009/022047s011s016s017s019s022lbl.pdf (accessed October 2018).Google Scholar

Maher, RL, Hanlon, J, Hajjar, ER. Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety. 2013; 13(1): 57–65.CrossRefGoogle ScholarPubMed

Gupta, S, Masand, P, Madhusoodanan, S. Side effects of atypical antipsychotics in the geriatric population. Current Psychosis and Therapeutics Reports. 2005; 3(1): 26–31.CrossRefGoogle Scholar

Rochon, PA, Gurwitz, JH. Optimising drug treatment for elderly people: the prescribing cascade. British Medical Journal. 1997; 315(7115): 1096–9.CrossRefGoogle ScholarPubMed

Liperoti, R, Sganga, F, Landi, F, et al. Antipsychotic drug interactions and mortality among nursing home residents with cognitive impairment. Journal of Clinical Psychiatry. 2017; 78(1): e76–e82.CrossRefGoogle ScholarPubMed

Qato, DM, Wilder, J, Schumm, LP, Gillet, V, Alexander, GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Internal Medicine. 2016; 176(4): 473.CrossRefGoogle ScholarPubMed

Tan, JL, Eastment, JG, Poudel, A, Hubbard, RE. Age-related changes in hepatic function: an update on implications for drug therapy. Drugs and Aging. 2015; 32(12): 999–1008.CrossRefGoogle ScholarPubMed

Madhusoodanan, S, Velama, U, Parmar, J, Goia, D, Brenner, R. A current review of cytochrome P450 interactions of psychotropic drugs. Annals of Clinical Psychiatry. 2014; 26(2): 120–38.Google ScholarPubMed

Highlights of prescribing information: Invega. www.invega.com/prescribing-information (accessed October 2018).Google Scholar

Beedham, C, Miceli, JJ, Obach, RS. Ziprasidone metabolism, aldehyde oxidase, and clinical implications. Journal of Clinical Psychopharmacology. 2003; 23(3): 229–32.CrossRefGoogle ScholarPubMed

Ayano, G. First generation antipsychotics: pharmacokinetics, pharmacodynamics, therapeutic effects and side effects: a review. Research and Reviews: Journal of Chemistry 2016; 5(3): 53–63.Google Scholar

Muench, J, Hamer, AM Adverse effects of antipsychotic medications. American Family Physician. 2010; 81: 617–22.Google ScholarPubMed

Mulsant, B, Pollack, BG. Psychopharmacology. In American Psychiatric Publishing Textbook of Geriatric Psychiatry, ed. Steffens, DC, Blazer, DG, Thakur, ME. Washington DC: American Psychiatric Publishing, 2015: 527–88.Google Scholar

Kusumi, I, Boku, S, Takahashi, Y. Psychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesis. Psychiatry and Clinical Neurosciences. 2015; 69: 243–58.CrossRefGoogle ScholarPubMed

Liperoti, R, Onder, G, Landi, F, et al. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia. Journal of Clinical Psychiatry. 2009; 70(10): 1340–7.Google ScholarPubMed

American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2015; 63(11): 2227–46.Google Scholar

Sahlberg, M, Holm, E, Gislason, GH, et al. Association of selected antipsychotic agents with major adverse cardiovascular events and noncardiovascular mortality in elderly persons. Journal of the American Heart Association. 2015; 4(9): e001666.CrossRefGoogle ScholarPubMed

Nielsen, J, Graff, C, Kanters, JK, et al. Assessing QT interval prolongation and its associated risks with antipsychotics. CNS Drugs. 2011; 25(6): 473–90.CrossRefGoogle ScholarPubMed

Hulshof, TA, Zuidema, SU, Ostelo, RW, Luijendijk, HJ. The mortality risk of conventional antipsychotics in elderly patients: a systematic review and meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Directors Association. 2015; 16(10): 817–24.CrossRefGoogle ScholarPubMed

Stübner, S, Rustenbeck, E, Grohmann, R, et al. Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 2004; 37(Suppl 1): S54–64.Google ScholarPubMed

Shalev, A, Hermesh, H, Munitz, H. Mortality from neuroleptic malignant syndrome. Journal of Clinical Psychiatry. 1989; 50(1): 18–25.Google ScholarPubMed

Jeste, DV, Lacro, JP, Palmer, B. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. American Journal of Psychiatry. 1998; 155: 1521–9.Google Scholar

Jeste, DV, Caligiuri, MP. Tardive dyskinesia. Schizophrenia Bulletin. 1993; 19(2): 303–15.CrossRefGoogle ScholarPubMed

Glazer, WM, Morgenstern, H, Doucette, JT. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Journal of Clinical Psychiatry. 1993; 54(4): 133–9.Google ScholarPubMed

Center for Drug Evaluation and Research. Drug Safety and Availability. FDA Drug Safety Communication: FDA reporting mental health drug ziprasidone (Geodon) associated with rare but potentially fatal skin reactions. www.fda.gov/Drugs/DrugSafety/ucm426391.htmGoogle Scholar

Center for Drug Evaluation and Research. Drug Safety and Availability. FDA Drug Safety Communication: Serious allergic reactions reported with the use of Saphris (asenapine maleate). www.fda.gov/Drugs/DrugSafety/ucm270243.htm (accessed October 2018).Google Scholar

Sajatovic, M, Madhusoodanan, S, Brenner, R. Schizophrenia in the elderly. CNS Drugs. 2000; 13(2): 103–15.CrossRefGoogle Scholar

Khan, AY, Redden, W, Ovais, M, et al. Current concepts in the diagnosis and treatment of schizophrenia in later life. Current Geriatric Reports. 2015; 4(4): 290–300.CrossRefGoogle Scholar

Alexopoulos, GS, Streim, J, Carpenter, D, et al. Using antipsychotic agents in older patients. Journal of Clinical Psychiatry 2004; 65(Suppl 2): 5–99; discussion: 100–2; quiz: 103–4.Google ScholarPubMed

Liu, AY, Rajji, TK, Blumberger, DM, Daskalakis, ZJ, Mulsant, BH. Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression. American Journal of Geriatric Psychiatry. 2014; 22(3): 216–40.CrossRefGoogle ScholarPubMed

Valenstein, M, Blow, FC, Copeland, LA, et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophrenia Bulletin. 2004; 30(2): 255–64.CrossRefGoogle ScholarPubMed

Jeste, DV, Maglione, JE. Treating older adults with schizophrenia: challenges and opportunities. Schizophrenia Bulletin. 2013; 39(5): 966–8.CrossRefGoogle ScholarPubMed

Suzuki, T, Uchida, H. Successful withdrawal from antipsychotic treatment in elderly male inpatients with schizophrenia: description of four cases and review of the literature. Psychiatry Research. 2014; 220(1–2): 152–7.CrossRefGoogle ScholarPubMed

Graff-Guerrero, A, Rajji, TK, Mulsant, BH, et al. Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study. JAMA Psychiatry. 2015; 72(9): 927–34.CrossRefGoogle ScholarPubMed

U.S. Census Bureau. The next four decades: the older population in the United States: 2010 to 2050. 2010. www.census.gov/prod/2010pubs/p25-1138.pdf (accessed October 2018).Google Scholar

Cohen, CI. Studies of the course and outcome of schizophrenia in later life. Psychiatric Services (Washington, DC). 1995; 46(9): 877–9, 889.Google ScholarPubMed

Jeste, DV, Alexopoulos, GS, Bartels, SJ, et al. Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Archives of General Psychiatry. 1999; 56(9): 848–53.CrossRefGoogle ScholarPubMed

Cohen, CI. Practical geriatrics: directions for research and policy on schizophrenia and older adults: summary of the GAP committee report. Psychiatric Services (Washington, DC). 2000; 51(3): 299–302.CrossRefGoogle ScholarPubMed

Walker, ER, McGee, RE, Druss, BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015; 72(4): 334–41.CrossRefGoogle ScholarPubMed

Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015; 72(12): 1172–81.CrossRefGoogle ScholarPubMed

Jeste, DV, Gladsjo, JA, Lindamer, LA, Lacro, JP. Medical comorbidity in schizophrenia. Schizophrenia Bulletin. 1996; 22(3): 413–30.CrossRefGoogle ScholarPubMed

Rystedt, IB, Bartels, SJ. Medical comorbidity. In: Mueser, KT, Jeste, DV, eds. Clinical Handbook of Schizophrenia. New York: Guilford; 2008: 424–36.Google Scholar

Bartels, SJ, Mueser, KT, Miles, KM. A comparative study of elderly patients with schizophrenia and bipolar disorder in nursing homes and the community. Schizophrenia Research. 1997; 27(2–3): 181–90.CrossRefGoogle ScholarPubMed

Horan, ME, Muller, JJ, Winocur, S, Barling, N. Quality of life in boarding houses and hostels: a residents' perspective. Community Mental Health Journal. 2001; 37(4): 323–34.CrossRefGoogle ScholarPubMed

DE Hert, M, Correll, CU, Bobes, J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011; 10(1): 52–77.CrossRefGoogle ScholarPubMed

Corbin, JM, Strauss, AL. Unending Work and Care: Managing Chronic Illness at Home. San Francisco, CA: Jossey-Bass Publishers; 1988.Google Scholar

Whiteman, KL, Naslund, JA, DiNapoli, EA, Bruce, ML, Bartels, SJ. Systematic review of integrated general medical and psychiatric self-management interventions for adults with serious mental illness. Psychiatric Services (Washington, DC). 2016; 67(11): 1213–25.CrossRefGoogle ScholarPubMed

Druss, BG, Zhao, L, von Esenwein, SA, et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophrenia Research. 2010; 118(1–3): 264–70.CrossRefGoogle Scholar

Lorig, KR, Sobel, DS, Stewart, AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Medical Care. 1999; 37(1): 5–14.CrossRefGoogle ScholarPubMed

Wingood, GM, DiClemente, RJ. The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. Journal of Acquired Immune Deficiency Syndromes. 2008; 47(Suppl 1): S40–6.CrossRefGoogle Scholar

Druss, BG, Singh, M, von Esenwein, SA, et al. Peer-led self-management of general medical conditions for patients with serious mental illnesses: a randomized trial. Psychiatric Services (Washington, DC). 2018; 69(5): 529–35.CrossRefGoogle ScholarPubMed

Sajatovic, M, Dawson, NV, Perzynski, AT, et al. Best practices: optimizing care for people with serious mental illness and comorbid diabetes. Psychiatric Services (Washington, DC). 2011; 62(9): 1001–3.CrossRefGoogle ScholarPubMed

Bauer, MS, McBride, L. Structured Group Psychotherapy for Bi-polar Disorder: The Life Goals Program. New York: Springer; 2003.Google Scholar

McKibbin, CL, Patterson, TL, Norman, G, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophrenia Research. 2006; 86(1–3): 36–44.CrossRefGoogle ScholarPubMed

Sajatovic, M, Gunzler, DD, Kanuch, SW, et al. A 60-week prospective RCT of a self-management intervention for individuals with serious mental illness and diabetes mellitus. Psychiatric Services (Washington, DC). 2017; 68(9): 883–90.CrossRefGoogle ScholarPubMed

Mueser, KT, Bartels, SJ, Santos, M, Pratt, SI, Riera, EG. Integrated illness management and recovery: a program for integrating physical and psychiatric illness self-management in older persons with severe mental illness. American Journal of Psychiatric Rehabilitation. 2012; 15(2): 131–56.CrossRefGoogle Scholar

Bartels, SJ, Pratt, SI, Mueser, KT, et al. Integrated IMR for psychiatric and general medical illness for adults aged 50 or older with serious mental illness. Psychiatric Services (Washington, DC). 2014; 65(3): 330–7.CrossRefGoogle ScholarPubMed

Mueser, KT, Corrigan, PW, Hilton, DW, et al. Illness management and recovery: a review of the research. Psychiatric Services (Washington, DC). 2002; 53(10): 1272–84.CrossRefGoogle ScholarPubMed

Pratt, SI, Van Citters, AD, Mueser, KT, Bartels, SJ. Psychosocial rehabilitation in older adults with serious mental illness: a review of the research literature and recommendations for development of rehabilitative approaches. American Journal of Psychiatric Rehabilitation. 2008; 11(1): 7–40.CrossRefGoogle Scholar

Pratt, SI, Bartels, SJ, Mueser, KT, Forester, B. Helping older people experience success: an integrated model of psychosocial rehabilitation and health care management for older adults with serious mental illness. American Journal of Psychiatric Rehabilitation. 2008; 11(1): 41–60.CrossRefGoogle Scholar

Bartels, SJ, Pratt, SI. Psychosocial rehabilitation and quality of life for older adults with serious mental illness: recent findings and future research directions. Current Opinion in Psychiatry. 2009; 22(4): 381–5.CrossRefGoogle ScholarPubMed

Bartels, SJ, Forester, B, Mueser, KT, et al. Enhanced skills training and health care management for older persons with severe mental illness. Community Mental Health Journal. 2004; 40(1): 75–90.CrossRefGoogle ScholarPubMed

Patterson, TL, McKibbin, C, Taylor, M, et al. Functional adaptation skills training (FAST): a pilot psychosocial intervention study in middle-aged and older patients with chronic psychotic disorders. American Journal of Geriatric Psychiatry. 2003; 11(1): 17–23.CrossRefGoogle Scholar

McQuaid, JR, Granholm, E, McClure, FS, et al. Development of an integrated cognitive-behavioral and social skills training intervention for older patients with schizophrenia. Journal of Psychotherapy Practice and Research. 2000; 9(3): 149–56.Google ScholarPubMed

Mueser, KT, Pratt, SI, Bartels, SJ, et al. Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. Journal of Consulting and Clinical Psychology. 2010; 78(4): 561–73.CrossRefGoogle ScholarPubMed

Bartels, SJ, Pratt, SI, Mueser, KT, et al. Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness. American Journal of Geriatric Psychiatry. 2014; 22(11): 1251–61.CrossRefGoogle ScholarPubMed

Vaccaro, JV, Liberman, RP, Wallace, CJ, Blackwell, G. Combining social skills training and assertive case management: the social and independent living skills program of the Brentwood Veterans Affairs Medical Center. New Directions for Mental Health Services. 1992;(53): 33–42.CrossRefGoogle ScholarPubMed

Patterson, TL, Mausbach, BT, McKibbin, C, et al. Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophrenia Research. 2006; 86(1–3): 291–9.CrossRefGoogle Scholar

Patterson, TL, Bucardo, J, McKibbin, CL, et al. Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophrenia Bulletin. 2005; 31(4): 922–30.CrossRefGoogle ScholarPubMed

Mausbach, BT, Bucardo, J, Cardenas, V, et al. Evaluation of a culturally tailored skills intervention for Latinos with persistent psychotic disorders. American Journal of Psychiatric Rehabilitation. 2008; 11(1): 61–75.CrossRefGoogle ScholarPubMed

Beck, AT, Rush, AJ, Shaw, BF, Emery, G. Cognitive Therapy of Depression. New York: Guilford; 1987.Google Scholar

Kingdon, D, Turkington, D. Cogntitive-Behavioral Therapy of Schizophrenia. New York: Guilford; 1994.Google ScholarPubMed

Liberman, RP, Van Putten, T, Marshall, BD, Jr., et al. Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. American Journal of Psychiatry. 1994; 151(5): 756–9.Google ScholarPubMed

Psychiatric Rehabilitation Consultants. Modules in the UCLA social and independent living skill series. Camarillo, C.A.: Psychiatric Rehabilitation Consultants; 1991.Google Scholar

Granholm, E, McQuaid, JR, McClure, FS, et al. A randomized, controlled trial of cognitive behavioral social skills training for middle-aged and older outpatients with chronic schizophrenia. American Journal of Psychiatry. 2005; 162(3): 520–9.CrossRefGoogle ScholarPubMed

Laursen, TM, Munk-Olsen, T, Vestergaard, M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Current Opinion in Psychiatry. 2012; 25(2): 83–8.CrossRefGoogle ScholarPubMed

Yarborough, BJ, Janoff, SL, Stevens, VJ, Kohler, D, Green, CA. Delivering a lifestyle and weight loss intervention to individuals in real-world mental health settings: Lessons and opportunities. Translational Behavioral Medicine. 2011; 1(3): 406–15.CrossRefGoogle ScholarPubMed

Svetkey, LP, Harsha, DW, Vollmer, WM, et al. Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics. Annals of Epidemiology. 2003; 13(6): 462–71.CrossRefGoogle ScholarPubMed

Yarborough, BJ, Leo, MC, Stumbo, S, Perrin, NA, Green, CA. STRIDE: a randomized trial of a lifestyle intervention to promote weight loss among individuals taking antipsychotic medications. BMC Psychiatry. 2013; 13: 238.CrossRefGoogle Scholar

Green, CA, Yarborough, BJ, Leo, MC, et al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. American Journal of Psychiatry. 2015; 172(1): 71–81.CrossRefGoogle ScholarPubMed

Van Citters, AD, Pratt, SI, Jue, K, et al. A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness. Community Mental Health Journal. 2010; 46(6): 540–52.CrossRefGoogle ScholarPubMed

Bartels, SJ, Pratt, SI, Aschbrenner, KA, et al. Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatric Services. 2013; 64(8): 729–36.CrossRefGoogle ScholarPubMed

Samitz, G, Egger, M, Zwahlen, M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. International Journal of Epidemiology. 2011; 40(5): 1382–400.CrossRefGoogle ScholarPubMed

Larsson, UE, Reynisdottir, S. The six-minute walk test in outpatients with obesity: reproducibility and known group validity. Physiotherapy Research International. 2008; 13(2): 84–93.CrossRefGoogle ScholarPubMed

Wise, RA, Brown, CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. Journal of Chronic Obstructive Pulmonary Disease. 2005; 2(1): 125–9.CrossRefGoogle ScholarPubMed

Rasekaba, T, Lee, AL, Naughton, MT, Williams, TJ, Holland, AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Internal Medicine Journal. 2009; 39(8): 495–501.CrossRefGoogle ScholarPubMed

Bartels, SJ, Pratt, SI, Aschbrenner, KA, et al. Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. American Journal of Psychiatry. 2015; 172(4): 344–52.CrossRefGoogle ScholarPubMed

Elmer, PJ, Obarzanek, E, Vollmer, WM, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Annals of Internal Medicine. 2006; 144(7): 485–95.CrossRefGoogle ScholarPubMed

Whelton, PK, Appel, LJ, Espeland, MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998; 279(11): 839–46.CrossRefGoogle Scholar

Daumit, GL, Dickerson, FB, Wang, NY, et al. A behavioral weight-loss intervention in persons with serious mental illness. New England Journal of Medicine. 2013; 368(17): 1594–602.CrossRefGoogle ScholarPubMed

Casagrande, SS, Jerome, GJ, Dalcin, AT, et al. Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: the ACHIEVE trial. BMC Psychiatry. 2010; 10: 108.CrossRefGoogle ScholarPubMed

Vazin, R, McGinty, EE, Dickerson, F, et al. Perceptions of strategies for successful weight loss in persons with serious mental illness participating in a behavioral weight loss intervention: a qualitative study. Psychiatric Rehabilitation Journal. 2016; 39(2): 137–46.CrossRefGoogle Scholar

Leutwyler, H, Hubbard, E, and Dowling, G. Adherence to a videogame-based physical activity program for older adults with schizophrenia. Games for Health Journal. 2014; 3(4): 227–233.CrossRefGoogle ScholarPubMed

Leutwyler, H, Hubbard, E, Cooper, B, and Dowling, G. The impact of a videogame-based pilot physical activity program in older adults with schizophrenia on subjectively and objectively measured physical activity. Front Psychiatry. 2015; 6: 180.CrossRefGoogle ScholarPubMed

Nasar, S. (1998). A Beautiful Mind: A Biography of John Forbes Nash. New York: Simon & Schuster.Google Scholar

Saks, E.R. (2007). The Center Cannot Hold: My Journey Through Madness. New York: Hyperion.Google Scholar

Band-Winterstein, T., Avieli, H., Smeloy, Y. (2015). “He is still my son”: aging and living in the shadow of an abusive adult child with mental disorder. In Maxwell, S.R., Blair, S.L. (eds.), Violence and Crime in the Family: Patterns, Causes, and Consequences. (Contemporary Perspectives in Family Research, Volume 9). Bingley, UK: Emerald Groups Publishing Limited, 155–76.Google Scholar

Iglehart, J.K. (2016). Decriminalizing mental illness: the Miami model. New England Journal of Medicine, 374, 1701–3.CrossRefGoogle ScholarPubMed

Ghose, S., Greenberg, J. (2009). Aging fathers of adult children with schizophrenia: the toll of caregiving on their physical and mental health. Psychiatric Services, 60, 982–4.Google Scholar

Lefley, H.P. (1996). Family Caregiving in Mental Illness. Thousand Oaks, CA: Sage.Google Scholar

Lefley, H.P. (2010). Treating difficult cases in a psychoeducational family support group for serious mental illness. Journal of Family Psychotherapy, 21, 253–68.CrossRefGoogle Scholar

Smith, G.C. (2003). Patterns and predictors of service use and unmet needs among aging families of adults with severe mental illness. Psychiatric Services, 54, 871–7.CrossRefGoogle ScholarPubMed

Hatfield, A.B., Lefley, H.P. (2000). Helping elderly caregivers plan for the future care of a relative with mental illness. Psychiatric Rehabilitaion Journal, 24, 103–7.Google Scholar

Lefley, H.P., Hatfield, A.B. (1999). Helping parental caregivers and mental health consumers cope with parental aging and loss. Psychiatric Services, 50, 369–75.CrossRefGoogle ScholarPubMed

Stein, L., Test, M. (1980). Alternative to mental hospital treatment. Archives of General Psychiatry, 37, 392–7.CrossRefGoogle ScholarPubMed

Lefley, H.P. (2010) Mental health systems in cross-cultural context. In Shcheid, T.L., Brown, T.N. (eds.), Handbook for the Study of Mental Health: Social Contexts, Theories, and Systems. 2nd edn. New York: Cambridge University Press, 135–61.Google Scholar

Lam, P.C.W., Ng, P., Pan, J., Yung, D.W.K. (2015). Ways of coping of Chinese caregivers for family members with schizophrenia in two metropolitan cities: Guangzhou and Hong Kong, China. International Journal of Social Psychiatry, 61, 591–9.CrossRefGoogle ScholarPubMed

Zeng, Y., Zhou, Y., Lin, J. (2017). Perceived burden and quality of life in Chinese caregivers of people with serious mental illness: a comparison cross-sectional survey. Perspectives in Psychiatric Care, 53, 183–9.CrossRefGoogle ScholarPubMed

Chadda, R.K. (2014). Caring for the family caregivers of persons with mental illness. Indian Journal of Psychiatry, 56, 221.CrossRefGoogle ScholarPubMed

Von Kardoff, E., Soltaninejad, A., Kamali, M., Eslami Shahrbabaki, M. (2016). Family caregiver burden in mental illesses: the case of affective disorders and schizophrenia: a qualitative exploratory study. Nordic Journal of Psychiatry, 70, 248–54.Google Scholar

Hatfield, A.B. Planning for the Future Care of Relatives with Mental Illnesses. Baltimore: Maryland Department of Health and Mental Hygiene.Google Scholar

Meriden, . (2017). The Meriden Family Programme. Meriden, (2017). 4(4), 19.Google Scholar

Lefley, H.P. Family Psychoeducation for Serious Mental Illness. (Evidence-Based Practice Series: V.1.) New York: Oxford University Press.CrossRefGoogle Scholar

Dixon, L., McFarlane, W.R., Lefley, H., et al. (2001). Evidence-based practices for services to families of people with psychiatric disabilites. Psychiatric Services, 52, 903–10.CrossRefGoogle Scholar

Lefley, H.P. (2009). A psychoeducational support group for persons with serious mental illness. Journal for Specialists in Group Work, 34, 369–81.CrossRefGoogle Scholar

Baltes, P.B. and Baltes, M.M.. Psychological perspectives on successful aging: the model of selective optimization with compensation. In Successful Aging: Perspectives from the Behavioral Sciences, ed. Baltes, P.B. and Baltes, M.M., Cambridge, UK: Cambridge University Press, 1990: 1–34.CrossRefGoogle Scholar

Jeste, D.V., Depp, C.A., and Vahia, I.V.. Successful cognitive and emotional aging. World Psychiatry 2010; 9(2): 78–84.CrossRefGoogle ScholarPubMed

Cohen, C.I.. Outcome of schizophrenia into later life: an overview. Gerontologist 1990; 30: 790–7.CrossRefGoogle ScholarPubMed

Karim, S., Overshott, R., and Burns, A.. Older people with chronic schizophrenia. Aging and Mental Health 2005; 9(4): 315–24.CrossRefGoogle ScholarPubMed

McGlashan, T.H. and Johannessen, J.O.. Early detection and intervention with schizophrenia: rationale. Schizophrenia Bulletin 1996; 22(2): 201–22.Google ScholarPubMed

Bobes, J., Arango, C., Garcia-Garcia, M., et al. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. Journal of Clinical Psychiatry 2010; 71(3): 280.CrossRefGoogle ScholarPubMed

Cohen, C.I., Meesters, P.D., and Zhao, J.. New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry 2015; 2(4): 340–50.CrossRefGoogle ScholarPubMed

Flanagan, E.H., Davidson, L., and Strauss, J. S.. Issues for DSM-V: incorporating patients’ subjective experiences. American Journal of Psychiatry 2007; 164(3): 391–2.CrossRefGoogle ScholarPubMed

Strauss, J.S.. Prognosis in schizophrenia and the role of subjectivity. Schizophrenia Bulletin 2008; 34(2): 201–3.Google ScholarPubMed

Walker, E., Kestler, L., Bollini, A., et al. Schizophrenia: etiology and course. Annual Review of Psychology 2003; 55: 401–30.Google Scholar

Williams, B. and Healy, D.. Perceptions of illness causation among new referrals to a community mental health team: “explanatory model” or “exploratory map”? Social Science and Medicine 2001; 53: 465–76.CrossRefGoogle Scholar

Baker, A.E.Z. and Procter, N.G.. A qualitative inquiry into consumer beliefs about the causes of mental illness. Journal of Psychiatric and Mental Health Nursing 2013; 20(5): 442–7.CrossRefGoogle ScholarPubMed

Araten-Bergman, T., Avieli, H., Mushkin, P., et al. How aging individuals with schizophrenia experience the self-etiology of their illness: a reflective lifeworld research approach. Aging and Mental Health 2016; 20(11): 1147–56.CrossRefGoogle ScholarPubMed

Khalsa, S.R., McCarthy, K.S., Sharpless, B.A., et al. Beliefs about the causes of depression and treatment preferences. Journal of Clinical Psychology 2011; 67(6): 539–49.CrossRefGoogle ScholarPubMed

Sheikh, S. and Furnham, A.. A cross-cultural study of mental health beliefs and attitudes towards seeking professional help. Social Psychiatry and Psychiatric Epidemiology 2000; 35(7): 326–34.CrossRefGoogle ScholarPubMed

Bhui, K. and Bhugra, D.. Explanatory models for mental distress: implications for clinical practice research. British Journal of Psychiatry 2002; 181: 6–7.CrossRefGoogle Scholar

Stein, C.H. and Wemmerus, V.A.. Searching for a normal life: personal accounts of adults with schizophrenia, their parents and well‐siblings. American Journal of Community Psychology 2001; 29(5): 725–46.CrossRefGoogle ScholarPubMed

Solano, N.H. and Whitbourne, S.K., Coping with schizophrenia: patterns in later adulthood. International Journal of Aging and Human Development 2001; 53(1): 1–10.CrossRefGoogle ScholarPubMed

Barrowclough, C., Berry, K.K.L., Byrne, E.E.J., and Purandare, N.. Coping processes in older people with schizophrenia: an investigation of appraisals, coping and social support in patients and non-clinical controls. Social Psychiatry and Psychiatric Epidemiology 2006; 41(4): 280–4.Google Scholar

Cohen, C.I., Hassamal, S.K., and Begum, N.. General coping strategies and their impact on quality of life in older adults with schizophrenia. Schizophrenia Research 2011; 127(1): 223–8.CrossRefGoogle ScholarPubMed

Ogden, L.P.. “My Life as it is has Value”: A Narrative Approach to Understanding Life Course Experiences of Older Adults with Schizophrenia. Doctoral thesis, Columbia University, 2012.Google Scholar

Shibusawa, T. and Padgett, D.. The experiences of “aging” among formerly homeless adults with chronic mental illness: a qualitative study. Journal of Aging Studies 2009; 23: 188–96.CrossRefGoogle Scholar

Bartels, S.J. and Pratt, S.. Psychosocial rehabilitation and quality of life for older adults with serious mental illness: recent findings and future research directions. Current Opinion in Psychiatry 2009; 22: 381–5.CrossRefGoogle ScholarPubMed

Magliano, L., Fiorillo, A., Malangone, C., et al. Social network in long-term diseases: a comparative study in relatives of persons with schizophrenia and physical illnesses versus a sample from the general population. Social Science and Medicine 2006; 62(6): 1392–402.CrossRefGoogle Scholar

Palmer, B.W., Martin, A.S., Depp, C.A., et al. Wellness within illness: happiness in schizophrenia. Schizophrenia Research 2014; 159(1): 151–6.CrossRefGoogle ScholarPubMed

Avieli, H., Mushkin, P., Araten-Bergman, T., et al. Aging with schizophrenia: a lifelong experience of multidimensional losses and suffering. Archives of Psychiatric Nursing 2016; 30(2): 230–6.CrossRefGoogle ScholarPubMed

Larsen, E.B. and Gerlach, J.. Subjective experience of treatment, side‐effects, mental state and quality of life in chronic schizophrenic out‐patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica 1996; 93(5): 381–8.CrossRefGoogle ScholarPubMed

Higginbottom, G. and Liamputtong, P. (eds.) Participatory Qualitative Research Methodologies in Health. Thousand Oaks, CA: Sage, 2015.CrossRefGoogle Scholar

Pentland, W., Miscio, G., Eastabrook, S., et al. Aging women with schizophrenia. Psychiatric Rehabilitation Journal 2003; 26: 290–302.CrossRefGoogle ScholarPubMed

Shepherd, S., Depp, C.A., Harris, G., et al. Perspectives on schizophrenia over the lifespan: a qualitative study. Schizophrenia Bulletin 2012; 38: 295–303.CrossRefGoogle ScholarPubMed

Martinsson, G., Fagerberg, I., Lindholm, C., et al. Struggling for existence: life situation experiences of older persons with mental disorders. International Journal of Qualitative Studies on Health and Well-being 2012; 7(1): 18422.CrossRefGoogle ScholarPubMed

Patton, M.Q.. Qualitative Research and Evaluation Methods, 3rd edn. Thousand Oaks, CA: Sage, 2002.Google Scholar

Morse, J.M.. Determining sample size. Qualitative Health Research 2000; 10: 3–5.CrossRefGoogle Scholar

Kvale, S.. The 1,000-page question. Qualitative Inquiry 1996; 2(3): 275–84.CrossRefGoogle Scholar

Padgett, D.K.. Qualitative Methods in Social Work Research, Thousand Oaks, CA: Sage Publications, 2016.Google Scholar

Mushkin, P., Band-Winterstein, T., and Avieli, H.. “Like every normal person”: like every normal person?! The paradoxical effect of aging with schizophrenia. Qualitative Health Research 2018; 28(6): 977–86.CrossRefGoogle ScholarPubMed

Heidegger, M.. What is metaphysics? Basic Writings, New York, NY: Routledge, 1993: 89–110.Google Scholar

Jacob, K.S.. Insight in psychosis: an independent predictor of outcome or an explanatory model of illness? Asian Journal of Psychiatry 2014; 11: 65–71.CrossRefGoogle ScholarPubMed

Leamy, M., Bird, V., Le Boutillier, C., et al. Conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. British Journal of Psychiatry 2011; 199(6): 445–52.CrossRefGoogle ScholarPubMed

Andresen, R., Oades, L G., and Caputi, P.. Psychological Recovery: Beyond Mental Illness. Chichester, UK: John Wiley & Sons, 2011.CrossRefGoogle Scholar

Leventhal, H. and Nerenz, D.. The assessment of illness cognition. In Measurement Strategies in Health Psychology, ed. Karoly, P.. New York: John Wiley, 1985.Google Scholar

Karp, D.A.. Illness ambiguity and the search for meaning. Journal of Contemporary Ethnography 1992; 21(2): 139–70.CrossRefGoogle Scholar

Lincoln, Y.S. and Guba, E.G.. Naturalistic Inquiry, Thousand Oaks, CA: Sage, 1985.CrossRefGoogle Scholar

Correia, F. and Schnieder, B. (eds.) Metaphysical Grounding: Understanding the Structure of Reality. Cambridge, UK: Cambridge University Press, 2012.CrossRefGoogle Scholar

Reker, G. T., Birren, J., and Svensson, C.. Restoring, maintaining, and enhancing personal meaning in life through autobiographical methods. In The Human Quest for Meaning: Theories, Research, and Applications. New York, NY: Routledge, 2013: 383–408.Google Scholar

Beaver, M.. Life review/reminiscent therapy. In Serving the Elderly, ed P. Kim. New York, NY: Aldine DeGruyter, 1991: 67–88.Google Scholar

Butler, R.N.. The life review: an interpretation of reminiscence in the aged. In New Thoughts on Old Age. Berlin Heidelberg: Springer, 196: 265–80.Google Scholar

Birren, J.E. and Cochran, K.N.. Telling the Stories of Life through Guided Autobiography Groups. Baltimore, MD: Taylor & Francis, 2001.Google Scholar

Oliver, M. and Barnes, C.. Disabled People and Social Policy: From Exclusion to Inclusion. London, UK: Addison Wesley Longman, 1998.Google Scholar

Nuevo, R, Chatterji, S, Verdes, E, et al. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophrenia Bulletin. 2010; 38: 475–85.Google ScholarPubMed

World Health Organization. World Health Statistics 2009. World Health Organization; 2009.Google Scholar

Cohen, CI, Meesters, PD, Zhao, J. New perspectives on schizophrenia in later life: implications for treatment, policy, and research. Lancet Psychiatry. 2015; 2: 340–50.CrossRefGoogle ScholarPubMed

Jeste, DV, Wolkowitz, OM, Palmer, BW. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophrenia Bulletin. 2011; 37: 451–5.CrossRefGoogle ScholarPubMed

Saha, S, Chant, D, Welham, J, McGrath, J. A systematic review of the prevalence of schizophrenia. PLoS Medicine. 2005; 2: e141.CrossRefGoogle ScholarPubMed

Bauer, SM, Schanda, H, Karakula, H, et al. Culture and the prevalence of hallucinations in schizophrenia. Comprehensive Psychiatry. 2011; 52: 319–25.CrossRefGoogle ScholarPubMed

Myers, NL. Update: schizophrenia across cultures. Current Psychiatry Reports. 2011; 13: 305–11.CrossRefGoogle ScholarPubMed

Patel, V, Farooq, S, Thara, R. What is the best approach to treating schizophrenia in developing countries? PLoS Medicine. 2007; 4: e159.CrossRefGoogle ScholarPubMed

Lauber, C, Rössler, W. Stigma towards people with mental illness in developing countries in Asia. International Review of Psychiatry. 2007; 19: 157–78.CrossRefGoogle ScholarPubMed

Ng, CH. The stigma of mental illness in Asian cultures. Australian and New Zealand Journal of Psychiatry. 1997; 31: 382–90.CrossRefGoogle ScholarPubMed

Yip, K-S. Taoism and its impact on mental health of the Chinese communities. International Journal of Social Psychiatry. 2004; 50: 25–42.CrossRefGoogle ScholarPubMed

Lin, K-M, Inui, TS, Kleinman, AM, Womack, WM. Sociocultural determinants of the help-seeking behavior of patients with mental illness. The Journal of Nervous and Mental Disease. 1982; 170: 78–85.CrossRefGoogle ScholarPubMed

Campion, J, Bhugra, D. Experiences of religious healing in psychiatric patients in South India. Social Psychiatry and Psychiatric Epidemiology. 1997; 32: 215–21.CrossRefGoogle ScholarPubMed

Al-Krenawi, A, Graham, JR, Dean, YZ, Eltaiba, N. Cross-national study of attitudes towards seeking professional help: Jordan, United Arab Emirates (UAE) and Arabs in Israel. International Journal of Social Psychiatry. 2004; 50: 102–14.CrossRefGoogle ScholarPubMed

Hooyman, N, Kiyak, HA. Social Gerontology: A Multidisciplinary Perspective, 9th edn. Boston, MA: Allyn & Bacon; 2011.Google Scholar

Levkoff, SE, Macarthur, IW, Bucknall, J. Elderly mental health in the developing world. Social Science and Medicine. 1995; 41: 983–1003.CrossRefGoogle ScholarPubMed

Kirkpatrick, B, Messias, E, Harvey, PD, Fernandez-Egea, E, Bowie, CR. Is schizophrenia a syndrome of accelerated aging? Schizophrenia Bulletin. 2007; 34: 1024–32.Google ScholarPubMed

Hendrie, HC, Tu, W, Tabbey, R, et al. Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care. American Journal of Geriatric Psychiatry. 2014; 22: 427–36.CrossRefGoogle ScholarPubMed

Vahia, IV, Diwan, S, Bankole, AO, et al. Adequacy of medical treatment among older persons with schizophrenia. Psychiatric Services. 2008; 59: 853–9.CrossRefGoogle ScholarPubMed

Jeste, D, Twamley, E, Eyler Zorrilla, L, et al. Aging and outcome in schizophrenia. Acta Psychiatrica Scandinavica. 2003; 107: 336–43.CrossRefGoogle ScholarPubMed

Putnam, KM, Harvey, PD, Parrella, M, et al. Symptom stability in geriatric chronic schizophrenic inpatients: a one-year follow-up study. Biological Psychiatry. 1996; 39: 92–9.CrossRefGoogle ScholarPubMed

Ran, M, Xiang, M, Huang, M, Shan, Y. Natural course of schizophrenia: 2-year follow-up study in a rural Chinese community. British Journal of Psychiatry. 2001; 178: 154–8.CrossRefGoogle Scholar

Subedi, S, Tausig, M, Subedi, J, Broughton, C, Williams-Blangero, S. Mental illness and disability among elders in developing countries: the case of Nepal. Journal of Aging and Health. 2004; 16: 71–87.CrossRefGoogle ScholarPubMed

Ran, M-S, Xiang, M-Z, Conwell, Y, et al. Comparison of characteristics between geriatric and younger subjects with schizophrenia in community. Journal of Psychiatric Research. 2004; 38: 417–24.CrossRefGoogle ScholarPubMed

Johnson, S, Sathyaseelan, M, Charles, H, Jeyaseelan, V, Jacob, KS. Insight, psychopathology, explanatory models and outcome of schizophrenia in India: a prospective 5-year cohort study. BMC Psychiatry. 2012; 12: 159.CrossRefGoogle ScholarPubMed

Vahia, IV, Vahia, VN. Schizophrenia in developing countries. In Clinical Handbook of Schizophrenia, ed. Mueser, KT, Jeste, DV. New York: Guilford Press; 2008: 549–58.Google Scholar

Agarwal, V, Abhijnhan, A, Raviraj, P. Ayurvedic medicine for schizophrenia. Cochrane Database of Systematic Reviews. 2007;(4): CD006867.Google ScholarPubMed

Chatterjee, S, Naik, S, Dabholkar, H, et al. Trials of interventions for people with psychosis. In Global Mental Health Trials, ed. Thornicroft, G, Patel, V. London: Oxford University Press, 2014: 141–59.Google Scholar

Rotondi, A, Haas, G, Anderson, C, et al. A clinical trial to test the feasibility of a telehealth psychoeducational intervention for persons with schizophrenia and their families: intervention and 3-month findings. Rehabilitation Psychology. 2005; 50: 325.CrossRefGoogle ScholarPubMed

Kaplan, WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Globalization and Health. 2006; 2: 9.CrossRefGoogle ScholarPubMed

Pan, S, Jordan-Marsh, M. Internet use intention and adoption among Chinese older adults: from the expanded technology acceptance model perspective. Computers in Human Behavior. 2010; 26: 1111–19.CrossRefGoogle Scholar

Patel, V, Cohen, A, Thara, R, Gureje, O. Is the outcome of schizophrenia really better in developing countries? Revista Brasileira de Psiquiatria. 2006; 28: 149–52.Google ScholarPubMed